StergiosMoschosMD

Oncology • Chapel Hill, NC

Melanoma

Physician

Join to view full profile

Dr. Moschos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moschos' full profile

Already have an account?

Office
170 Manning Drive
3116
Chapel Hill, NC 27514
Phone+1 919-843-7713

Summary

Melanoma medical oncology. Late preclinical, early clinical development. Non-invasive biomarkers of response to immune checkpoint inhibitors. Immuno-metabolism. Central thymic tolerance. Brain metastases

Education & Training

University of AthensClass of 1997

Certifications & Licensure

NC State Medical License 2011 - 2025
PA State Medical License 2002 - 2012
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Aug 17
Active, not recruiting
Phase 1, Phase 2
Roles: Principal Investigator

Publications & Presentations

PubMed

Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMa...
Raymond Y Huang, Gilbert Youssef, Thomas Nelson, Patrick Y Wen, Peter Forsyth
Journal of Clinical Oncology. 2025-01-03
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.
Kathleen Conway, Sharon N Edmiston, Amanda Vondras, Allison Reiner, David L Corcoran
JCO Precision Oncology. 2024-11-01
6 citations
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy.
Jacob Hall, Kevin Lui, Xianming Tan, John Shumway, Frances Collichio
Radiotherapy and Oncology. 2023-12-01

Press Mentions

Researchers Study Genetic Changes in Tumors of Recently Deceased Patients with MelanomaMay 2nd, 2023
Researchers Identify Lethal Molecular Alterations After Current Therapies Fail Patients with Metastatic MelanomaApril 27th, 2023
Cancer’s Capacity to Resist Treatment ThwartedJanuary 27th, 2023
Join now to see all